Evidence map›Paper›PMID 37918446›Full record

ReviewJournal of neuroscience methods2024

Practical solutions for including sex as a biological variable (SABV) in preclinical neuropsychopharmacological research.

Christina Dalla, Ivana Jaric, Pavlina Pavlidi, Georgia E Hodes, Nikolaos Kokras, Anton Bespalov, Martien J Kas, Thomas Steckler, Mohamed Kabbaj, Hanno Würbel and 7 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroscience methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Unpacking Ventral Pallidum GABA Neuron Contributions to Opioid Drug Reward in Rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Gendering the Menstrual Cycle in Behavioral Neuroendocrinology.American journal of human biology : the official journal of the Human Biology Council · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 5 countries.

Christina DallaDepartment of Pharmacology, Medical School, National and Kapodistrian University of Athens, Greece. Electronic address: cdalla@med.uoa.gr.
Ivana JaricAnimal Welfare Division, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Pavlina PavlidiDepartment of Pharmacology, Medical School, National and Kapodistrian University of Athens, Greece.
Georgia E HodesSchool of Neuroscience, Virginia Tech, Blacksburg, VA 24060, USA.
Nikolaos KokrasDepartment of Pharmacology, Medical School, National and Kapodistrian University of Athens, Greece; First Department of Psychiatry, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Anton BespalovPartnership for Assessment and Accreditation of Scientific Practice (PAASP GmbH), Heidelberg, Germany.
Martien J KasGroningen Institute for Evolutionary Life Sciences, University of Groningen, the Netherlands.
Thomas StecklerJanssen Pharmaceutica NV, Beerse, Belgium.
Mohamed KabbajDepartment of Biomedical Sciences & Neurosciences, College of Medicine, Florida State University, USA.
Hanno WürbelAnimal Welfare Division, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Jordan MarroccoDepartment of Biology, Touro University, New York, NY 10027, USA.
Jessica TollkuhnCold Spring Harbor Laboratory, USA.
Rebecca ShanskyDepartment of Psychology, Northeastern University, Boston, MA 02128, USA.
Debra BangasserNeuroscience Institute, Georgia State University, Atlanta, GA 30303, USA; Center for Behavioral Neuroscience, Georgia State University, Atlanta, GA 30303, USA.
Jill B BeckerDepartment of Psychology and Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI 48109, USA.
Margaret McCarthyUniversity of Maryland School of Medicine, Department of Pharmacology, Baltimore MD, USA.
Chantelle Ferland-BeckhamCohen Veterans Bioscience, New York, NY, USA. Electronic address: chantelle.ferlandbeckham@cohenbio.org.
National and Kapodistrian University of Athens · GRUniversity of Bern · CHCohen Veterans Bioscience · USCold Spring Harbor Laboratory · USFlorida State University · USGeorgia State University · USJanssen (Belgium) · BENortheastern University · USTouro College · USUniversity of Groningen · NLUniversity of Maryland, Baltimore · USUniversity of Michigan · USVirginia Tech · US

Funding

Breaking bonds in prairie volesR01MH125408 · NIMH · FLORIDA STATE UNIVERSITY · PI MOHAMED KABBAJ, ZUOXIN WANG · 2022 to 2026
$3.0M
Neurobiology of Ketamine AddictionR01DA043461 · NIDA · FLORIDA STATE UNIVERSITY · PI KABBAJ, MOHAMED · 2018 to 2022
$1.8M
Addressing Sex as a Biological Variable in Preclinical Pharmacology and Neuroscience Research: Accounting for Neglected Factors and Applying Practical Solutions to Enhance Rigor and ReproducibilityR25GM133017 · NIGMS · COHEN VETERANS BIOSCIENCE, INC. · PI FERLAND-BECKHAM, CHANTELLE · 2019 to 2021
$261k
NIDA NIH HHS R01 DA043461NIGMS NIH HHS R25 GM133017NIMH NIH HHS R01 MH125408
6 · The paper itself

Abstract

Recently, many funding agencies have released guidelines on the importance of considering sex as a biological variable (SABV) as an experimental factor, aiming to address sex differences and avoid possible sex biases to enhance the reproducibility and translational relevance of preclinical research. In neuroscience and pharmacology, the female sex is often omitted from experimental designs, with researchers generalizing male-driven outcomes to both sexes, risking a biased or limited understanding of disease mechanisms and thus potentially ineffective therapeutics. Herein, we describe key methodological aspects that should be considered when sex is factored into in vitro and in vivo experiments and provide practical knowledge for researchers to incorporate SABV into preclinical research. Both age and sex significantly influence biological and behavioral processes due to critical changes at different timepoints of development for males and females and due to hormonal fluctuations across the rodent lifespan. We show that including both sexes does not require larger sample sizes, and even if sex is included as an independent variable in the study design, a moderate increase in sample size is sufficient. Moreover, the importance of tracking hormone levels in both sexes and the differentiation between sex differences and sex-related strategy in behaviors are explained. Finally, the lack of robust data on how biological sex influences the pharmacokinetic (PK), pharmacodynamic (PD), or toxicological effects of various preclinically administered drugs to animals due to the exclusion of female animals is discussed, and methodological strategies to enhance the rigor and translational relevance of preclinical research are proposed.

Indexed as

Research DesignSex CharacteristicsAnimalsFemaleMaleReproducibility of ResultsSample SizeSex FactorsBehaviorCell linesHormonesPharmacodynamicPharmacokineticPreclinical researchSex as a biological variable (SABV)Sex differencesTherapeutics

Identifiers

PMID37918446
PMCPMC10842858
OpenAlexW4388086471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.